The COVID-19 pandemic has gripped nearly every country, confining billions and crippling economies worldwide. Yet, leading U.S. researchers from the University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP) predict it may continue for another two years.
Global scientists are racing to understand and combat COVID-19, from tracing its origins to developing treatments. With over 3.6 million cases and more than 250,000 deaths as of early 2020, this outbreak surpasses the 1968-1970 Hong Kong flu, which claimed about one million lives.
On April 30, 2020, CIDRAP released a comprehensive report urging preparation for prolonged COVID-19 impacts. Dr. Michael Osterholm, CIDRAP director, likened our position to the "second inning of a nine-inning baseball game," signaling we're just at the beginning.
The report outlines three plausible paths forward. First, recurring waves over one to two years with moderate peaks necessitating renewed social distancing. Second, a massive surge this fall triggering extended quarantines. Third, a gradual decline without overwhelming healthcare systems.
As countries like the United States ease restrictions, experts caution that deconfinement won't end the crisis. They foresee another 18 to 24 months of significant COVID-19 activity, with periodic "hot spots" requiring targeted quarantines or milder interventions based on local severity.
A vaccine remains the ultimate solution, but CIDRAP estimates availability in 10 to 14 months. Notably, on the same day, University of Oxford researchers reported promising early trials in macaques, hinting at potential rollout by September 2020—though uncertainties persist.
